The study clearly indicates that a potentiating impact of ATO in enhancing the oxidizing effect of VC is escalated to a potent cytotoxic impact selectively in KRAS-mutant cancer cells without affecting primary and other cancer cells. The gene discussed is KRAS; the disease is cancer.